Last Updated:
Name Designation Appointment Date Status
Anitha Reddy Vinta

Appointed as Designated Partner since November 2023

Designated Partner 20-Nov-2023 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rahul Battala

Appointed as Designated Partner since November 2023

Designated Partner 20-Nov-2023 Current
Swathi Kurnool

Appointed as Designated Partner since November 2023

Designated Partner 20-Nov-2023 Current

People Timeline

Explore the timeline of key personnel in Xeneo Therapeutics Llp's leadership journey.

Loading...
Contact Details
  • Address Hno 3-118/2/F Pno1 Bheem, Reddy Nagar Colony, Ghatkesar Telangana, 500092, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500092
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Xeneo Therapeutics Llp?
You can contact Xeneo Therapeutics Llp through their registered address at Hno 3-118/2/F Pno1 Bheem, Reddy Nagar Colony, Ghatkesar Telangana, 500092, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Xeneo Therapeutics Llp?
The current directors of Xeneo Therapeutics Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ANITHA REDDY VINTA
  • RAHUL BATTALA
  • SWATHI KURNOOL
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available